AstraZeneca Patents Sample Clauses
The "AstraZeneca Patents" clause defines the scope and ownership of patents held by AstraZeneca that are relevant to the agreement. It typically specifies which patents are included, such as those covering specific products, processes, or technologies, and may outline how these patents can be used or licensed by the other party. This clause ensures clarity regarding intellectual property rights, helping to prevent disputes over patent use and establishing the legal boundaries for both parties in relation to AstraZeneca's patented inventions.
AstraZeneca Patents. AstraZeneca will control and be responsible for all aspects of the Prosecution and Maintenance of all AstraZeneca Patents, subject to Section 7.2.3 and Section 7.2.4.
AstraZeneca Patents. Subject to this Section 6.2.2, AstraZeneca shall have the sole right, but not the obligation, through counsel of its choosing, to control the prosecution of any infringement described in Section 6.2.1 relating to the AstraZeneca Patents [...***...]. Prior to commencing any prosecution of an infringement claim with respect to the AstraZeneca Patents hereunder, AstraZeneca shall notify Horizon of its intent to commence such prosecution, and if Horizon in good faith believes that the prosecution of any such infringement of the AstraZeneca Patents by AstraZeneca could have a material adverse effect on the AstraZeneca Patents in the Horizon Territory or Horizon’s rights thereunder, Horizon shall promptly notify AstraZeneca after receiving such notice of intent and the Parties shall discuss in good faith the appropriate actions to be taken in response to such infringement; provided, however, that if the Parties are unable to come to a mutually acceptable resolution, then AstraZeneca shall be entitled to undertake such prosecution in its sole discretion, taking Horizon’s concerns into good faith consideration. Horizon shall have no right to prosecute any infringement of any AstraZeneca Patents.
AstraZeneca Patents. Company acknowledges and agrees that AstraZeneca has the sole right to prosecute and maintain the AstraZeneca Patents. TESARO shall promptly notify Company upon receiving notice from AstraZeneca that AstraZeneca has declined to continue to prosecute or maintain any AstraZeneca Patent in any jurisdiction.